Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8

Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey

Total article views   Abstract views HTML views PDF downloads Totals
5,798 Dovepress* 3,900 1,197+ 1,041 5,097
PubMed Central* 0 701 345 701
Totals 3,900 1,898 1,386 5,798
*Since 23 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar